Drug intelligence / Profile preview

Jingwu Keli

Development stage: Unknown
Lead developer: Shenqi Pharmaceutical
Administration: Oral

Overview

Jingwu Keli is a traditional Chinese medicine (TCM) formulated as oral granules, primarily manufactured by Guizhou Shenqi Pharmaceutical. The preparation is composed of four key herbal ingredients: *Polygonum multiflorum* (He Shou Wu), *Rehmannia glutinosa* (Di Huang), *Polygonatum sibiricum* (Huang Jing), and *Ligustrum lucidum* (Nu Zhen Zi). In traditional Chinese medicine theory, it is used to tonify the liver and kidneys and to nourish essence and blood. It is clinically indicated for the treatment of symptoms arising from liver and kidney deficiency, including premature graying of hair, hair loss (alopecia), dizziness, tinnitus, and weakness or aching in the lower back and knees. The product is widely available in the Chinese market as an approved TCM drug.

Brand names: 精乌颗粒
Other names: Jingwu Granules

Beyond the preview

Go deeper on Jingwu Keli.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jingwu Keli.

Explore the full profile